Results 121 to 130 of about 44,419 (235)

Metachronous Primary Pancreatic Neuroendocrine Tumor and Adenocarcinoma: A Case Report

open access: yesCancer Reports, Volume 9, Issue 6, June 2026.
ABSTRACT Background Pancreatic ductal adenocarcinoma (PDAC) has a dismal prognosis, with most patients presenting with advanced disease. Surgical resection remains the only potentially curative option, yet recurrence rates are high. Case We present a rare case of metachronous primary pancreatic neuroendocrine tumor (PanNET) and PDAC in a 71‐year‐old ...
Anastasia S. Fatyanova   +7 more
wiley   +1 more source

Detecting BRCA2 protein truncation in breast tissue biopsies to identify hereditary cancer.

open access: yes, 2009
Abstract #501 Background: Mutations in the BRCA2 gene are dominantly inherited but cause cancers when the wildtype allele has LOH (loss of heterozygosity) within the cancer.
V Clark   +4 more
core   +1 more source

Protein-protein interactions between the breast cancer susceptibility gene product BRCA2 and replication protein A

open access: yes, 1999
grantor: University of TorontoMutations in the BRCA2 gene predispose women to familial, early onset breast cancer. BRCA2 has been implicated in DNA double-strand break repair through its interaction with hRad51, which is known to be involved in
Ionescu, Daniela
core   +1 more source

Expression of BRCA1 and BRCA2 proteins and their correlation with clinical staging in breast cancer

open access: yesJournal of Cancer Research and Therapeutics, 2015
The purpose of this study was to evaluate the level of expression of the BRCA1 and BRCA2 proteins in sporadic breast cancer cases to determine the functional role of these genes in breast carcinogenesis.Paraffin embedded histologically proven invasive breast tissue sections that were obtained from 40 patients and the adjacent normal breast tissue ...
Suresh, Hedau   +5 more
openaire   +2 more sources

Unveiling Candidate Markers for Drug Resistance or Synthetic Lethality in Cervical Cancer: Integrative Analysis of Genetic and Pharmacoprofiling

open access: yesCancer Reports, Volume 9, Issue 6, June 2026.
ABSTRACT Introduction Systemic cervical cancer management continues to be challenging. Numerous chemotherapies have been approved, but predicting response is difficult due to the lack of biomarkers. Here, we analyze the genetic and protein profiles of 20 cervical cancer cell lines (CCCLs) and explore their correlation with drug response patterns to ...
Suzy Scholl   +10 more
wiley   +1 more source

Knockdown of the HR protein BRCA2 sensitizes glioma cells to O6AA chemotherapeutics.

open access: yes, 2013
(A) BRCA2 protein expression following knockdown was assessed by western blot. (B) Clonogenic survival following TMZ treatments in transient BRCA2 or non-sense (n.s.) siRNA transfected glioma cells.
Wynand Paul Roos (340507)   +2 more
core   +1 more source

Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk.

open access: yesPLoS Genetics, 2013
Common genetic variants contribute to the observed variation in breast cancer risk for BRCA2 mutation carriers; those known to date have all been found through population-based genome-wide association studies (GWAS).
Mia M Gaudet   +131 more
doaj   +1 more source

Lactate metabolism and lactylation in female reproductive diseases: From metabolic rewiring to biomarkers and translational therapeutics

open access: yesClinical and Translational Medicine, Volume 16, Issue 6, June 2026.
1. Lactate‐derived histone lactylation links glycolytic reprogramming to epigenetic regulation in female reproductive diseases. 2. In endometriosis, lactylation may promote inflammatory remodelling, immune dysregulation and ferroptosis resistance. 3. In PCOS, lactylation connects metabolic disturbance to granulosa‐cell dysfunction and hyperandrogenism.
Jiajun Qiao   +5 more
wiley   +1 more source

In silico analysis of the wild-type and mutant-type of BRCA2 gene

open access: yesJournal of Translational Medicine
Background The aim of this study was to conduct an in silico analysis of a novel compound heterozygous variant in breast cancer susceptibility gene 2 (BRCA2) to clarify its structure–function relationship and elucidate the molecular mechanisms underlying
Jingjing Li   +13 more
doaj   +1 more source

Lutein Influences Cisplatin Sensitivity Through Differential Regulation of DNA Damage Response Genes in Breast Cancer Cells

open access: yesJournal of Biochemical and Molecular Toxicology, Volume 40, Issue 6, June 2026.
Simultaneous treatment with lutein and cisplatin enhances oxidative DNA damage in breast cancer cells (MCF‐7 and MDA‐MB‐231) and promotes apoptosis specifically in MDA‐MB‐231 cells, while modulating DNA repair and damage response genes across cell types. Additionally, the combination increases cytotoxicity in HUVECs.
Funda Demirtas Korkmaz   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy